The effect of five different transferrin variants (TFv1, TFv2, TFv3, TFv4,
and TFv5) on the hemoglobin level, mean corpuscular volume (MCV), ferritin
level, percent transferrin saturation (%TS), and the unsaturated iron bindi
ng capacity (UIBC) was investigated in subjects with defined HFE haplotypes
, 919 persons undergoing health screening and 113 patients with clinical he
mochromatosis. The most common variant is TFv4; the population distribution
of this variant was also studied. None of the variants were found to have
an effect on any of the parameters of iron metabolism that were investigate
d. Moreover, the frequency of these variants in patients with clinically si
gnificant hemochromatosis was no different from that in the general populat
ion. We conclude that these polymorphisms in transferrin do not play a role
in the expression of hemochromatosis, nor do they produce any other signif
icant changes in iron metabolism.